# Brivaracetam to Reduce Neuropathic Pain in Chronic Spinal Cord Injury

> **NCT04379011** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 24 (actual)

## Conditions studied

- Spinal Cord Injuries

## Interventions

- **DRUG:** Brivaracetam
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04379011
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-01
- **Primary completion:** 2024-03-31
- **Final completion:** 2024-09-01
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04379011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04379011, "Brivaracetam to Reduce Neuropathic Pain in Chronic Spinal Cord Injury". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04379011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*